Literature DB >> 9101

Comparison of the action of BD 40 A and some other beta-adrenoceptor stimulants on the isolated trachea and atria of the guinea pig.

H Ida.   

Abstract

3-Formylamino-4-hydroxy-a-(N-1-methyl-2-p-methoxyphenethyl-aminomethyl)-benzylalcohol hemifumarate (BD 40A) was compared with isoproterenol, orciprenaline, trimetoquinol and salbutamol for its beta-adrenergic activity and selectivity in vitro. On trachea, the maximum relaxing responses to five agonists were similar, but the order of potency was BD 40A greater than trimetoquinol greater than isoproterenol greater than or equal to salbutamol greater than orciprenaline. On atria, the maximum chronotropic and inotropic responses to isoproterenol were greater than those to BD 40A, orciprenaline and trimetoquinol, and salbutamol caused the weakest cardiac stimulating effect. Namely, the latter four drugs appeared to be partial agonists on atria. Salbutamol showed the high selectivity for trachea, whereas orciprenaline and trimetoquinol were equipotent on trachea and atria. Isoproterenol was more potent on atria than on trachea. BD 40A had the highest bronchoselectivity among five agonists and seemed to act on the beta-adrenergic receptor directly.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9101

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  9 in total

Review 1.  Basic pharmacology of new long-acting sympathomimetics.

Authors:  C G Löfdahl
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.

Authors:  A Lindén; K F Rabe; C G Löfdahl
Journal:  Lung       Date:  1996       Impact factor: 2.584

Review 3.  Formoterol. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease.

Authors:  D Faulds; L M Hollingshead; K L Goa
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

4.  Tracheal relaxing effects and beta2 adrenoceptor selectivity of S1319, a novel sponge-derived bronchodilator agent, in isolated guinea-pig tissues.

Authors:  H Suzuki; A Ueno; M Takei; K Sindo; T Miura; M Sakakibara; T Higa; H Fukamachi
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

5.  Formoterol, fenoterol, and salbutamol as partial agonists for relaxation of maximally contracted guinea pig tracheae: comparison of relaxation with receptor binding.

Authors:  H Lemoine; C Overlack; A Köhl; H Worth; D Reinhardt
Journal:  Lung       Date:  1992       Impact factor: 2.584

6.  Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma.

Authors:  A Wallin; T Sandström; L Rosenhall; B Melander
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

7.  The effects of formoterol on plasma exudation produced by a localized acute inflammatory response to bradykinin in the tracheal mucosa of rats in vivo.

Authors:  S R O'Donnell; G P Anderson
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

8.  Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma.

Authors:  A Wallin; B Melander; L Rosenhall; T Sandström; L Wåhlander
Journal:  Thorax       Date:  1990-04       Impact factor: 9.139

9.  Multiplexed Optical Sensors in Arrayed Islands of Cells for multimodal recordings of cellular physiology.

Authors:  Christopher A Werley; Stefano Boccardo; Alessandra Rigamonti; Emil M Hansson; Adam E Cohen
Journal:  Nat Commun       Date:  2020-08-04       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.